174 related articles for article (PubMed ID: 6414212)
1. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
Branson HE; Schmer G; Theodor I; Pirkle H
Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
Schreiber WE; Schmer G
Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
Ebert RF; Schreiler WE; Bell WR
Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
[TBL] [Abstract][Full Text] [Related]
4. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
Andes WA; Chavin SI; Beltran G; Stuckey WJ
Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
[TBL] [Abstract][Full Text] [Related]
9. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
Lane DA; Cuddigan B; VanRoss M; Kakkar VV
Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
[TBL] [Abstract][Full Text] [Related]
10. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
[TBL] [Abstract][Full Text] [Related]
13. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
[TBL] [Abstract][Full Text] [Related]
14. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
Borrell M; Vila L; Solá J; Coll I; Gómez N; González N; Rutllant ML
Thromb Res; 1987 Mar; 45(5):591-9. PubMed ID: 3109061
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.
Ebert RF; Bell WR
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7318-22. PubMed ID: 6580646
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
Loreth RM; Meyer M; Albert FW
Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin.
Carrell N; McDonagh J
Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
Weinger RS; Rudy C; Moake JL; Conlon CL; Cimo PL
Am J Hematol; 1980; 9(3):237-48. PubMed ID: 6165239
[TBL] [Abstract][Full Text] [Related]
20. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
